Hodgkin Lymphoma & T-Cell Lymphomas

Hodgkin's lymphoma

HL morphology and IHC

HL pathogenesis

classical HL

classical HL presentation

HL staging

prognostic markers in HL

HL treatment

long term complications of early stage HL

“PET-adapted” treatment- advanced stage HL

PET adapted treatment

role of radiation (XRT) in HL

relapsed HL

hematologic malignancies expressing CD30

brentuximab vedotin- MOA

ECHELON-1: BV+AVD in advanced stage HL

challenges of treating elderly pts with HL

refractory HL: targeting PD-1

nivolumab in advanced HL

nivolumab in advanced HL conclusions

HL summary

T cell lymphomas

T cell lymphomas introduction

most common TCL subtypes

T-cell lymphoma survival

peripheral T cell lymphoma: PTCL-NOS

anaplastic large T cell lymphoma

mycosis fungoides- cutaneous T-cell lymphoma

adult T-cell leukemia/lymphoma (ATLL)

HTLV-1 and adult T-cell leukemia/lymphoma (ATLL)

angioimmunoblastic T-cell lymphoma

extranodal NK/T-cell lymphoma- nasal type

hepatosplenic T-cell lymphoma

enteropathy associated T-cell lymphoma presentation